Susquehanna International Group
AXN

Susquehanna International Group’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Susquehanna International Group’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-44,083
Closed -$7K – 10405
2017
Q3 		$7K Sell
44,083
-14,822
-25% -$4.04K ﹤0.01% 8701
2017
Q2 		$18K Sell
58,905
-44,114
-43% -$16K ﹤0.01% 9041
2017
Q1 		$42K Buy
103,019
+46,435
+82% +$20K ﹤0.01% 8628
2016
Q4 		$18K Sell
56,584
-88,445
-61% -$36.6K ﹤0.01% 9441
2016
Q3 		$80K Buy
+145,029
New +$97.5K ﹤0.01% 8017
2015
Q2 		– Sell
-30,465
Closed -$51K – 10699
2015
Q1 		$51K Buy
+30,465
New +$28.4K ﹤0.01% 9148
2014
Q2 		– Sell
-10,328
Closed -$4K – 10329
2014
Q1 		$4K Buy
+10,328
New +$3.69K ﹤0.01% 8811

Susquehanna International Group's AXN Position: Q4 2017 in Review

Susquehanna International Group sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2017, closing a stake of 44,083 shares — an estimated $7K sold.

Susquehanna International Group first reported a position in AXN in Q1 2014 and held it in 7 quarters. The position peaked at $80K in Q3 2016. 0 funds tracked by Wall St. Rank hold AXN as of Q4 2017.

  • Susquehanna International Group reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2017 after selling out during the quarter.
  • Susquehanna International Group sold 44,083 Aoxing Pharmaceutical Company Inc. shares in Q4 2017, an estimated $7K.
  • Susquehanna International Group first reported a position in Aoxing Pharmaceutical Company Inc. in Q1 2014 and held it in 7 quarters.
  • Susquehanna International Group's Aoxing Pharmaceutical Company Inc. position peaked at $80K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.